Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Exosome-Mediated Enhancement of Fat Graft Retention: A Comparative Preclinical Study with Stromal Vascular Fraction.

Zhu Y., Hong KY., Chang H.

Animal Study on Facial Rejuvenation, published in Aesthetic Plast Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Aesthetic Plast Surg (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41249525
PMCID
PMC12855394
DOI
10.1007/s00266-025-05350-5

Abstract (original English)

Background Cell-assisted lipotransfer (CAL) is a fat grafting technique that enhances graft survival by supplementing grafts with autologous stromal vascular fraction (SVF) or adipose-derived stromal cells (ASCs). However, its clinical translation has been hindered owing to inherent biological variability, potential cell viability issues, tumorigenic risk, and the complex regulatory landscape associated with cell-based therapies. To overcome these challenges, exosome has gained increasing attention as a promising non-cellular therapeutic modality capable of preserving key regenerative functions while minimizing relative concerns. This study aimed to compare the efficacy of SVF-enriched lipotransfer with fat co-transplanted with exosomes from ASCs to identify a reliable and clinically applicable non-cellular strategy for optimizing fat graft outcomes. Methods In vivo, minced human fat tissue mixed with phosphate-buffered saline, SVF cells, or exosomes was grafted into nude mice. Grafts were evaluated through microcomputed tomography at weeks 4 and 8 post-grafting and histological analysis at weeks 1 and 8 post-grafting. Results The exosome group showed a significantly higher volume retention rate than the control group at weeks 4 and 8 post-grafting. Histological analysis revealed that exosomes exhibited more pronounced effects in reducing inflammation, preserving perilipin-posi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsExosomesHumansMice, NudeGraft SurvivalMiceAdipose TissueStromal Vascular FractionFemaleMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research